Financial statements Aspharma
Balance sheet data of ASPHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 2 112 624,31 | 1 911 408,66 | 1 929 672,99 | 1 998 195,26 | 2 089 298,81 | 2 036 344,61 |
| A. Fixed assets | 346 935,69 | 281 634,33 | 196 531,66 | 152 209,78 | 182 399,44 | 108 391,93 |
| B. Current assets | 1 765 688,62 | 1 629 774,33 | 1 733 141,33 | 1 845 985,48 | 1 906 899,37 | 1 927 952,68 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 2 112 624,31 | 1 911 408,66 | 1 929 672,99 | 1 998 195,26 | 2 089 298,81 | 2 036 344,61 |
| A. Equity | -91 975,93 | -235 772,08 | -251 221,96 | -226 654,01 | -110 709,86 | -408 872,22 |
| B. Liabilities and provisions for liabilities | 2 204 600,24 | 2 147 180,74 | 2 180 894,95 | 2 224 849,27 | 2 200 008,67 | 2 445 216,83 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 2 107 697,56 | 2 067 323,32 | 2 097 644,28 | 2 167 167,12 | 2 086 136,53 | 2 344 353,44 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.